Literature DB >> 2060110

Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients.

H R Middlekauff1, W G Stevenson, L W Stevenson.   

Abstract

BACKGROUND: Atrial fibrillation is common in advanced heart failure, but its prognostic significance is controversial. METHODS AND
RESULTS: We evaluated the relation of atrial rhythm to overall survival and sudden death in 390 consecutive advanced heart failure patients. Etiology of heart failure was coronary artery disease in 177 patients (45%) and nonischemic cardiomyopathy or valvular heart disease in 213 patients (55%). Mean left ventricular ejection fraction was 0.19 +/- 0.07. Seventy-five patients (19%) had paroxysmal (26 patients) or chronic (49 patients) atrial fibrillation. Compared with patients with sinus rhythm, patients with atrial fibrillation did not differ in etiology of heart failure, mean pulmonary capillary wedge pressure on therapy, or embolic events but were more likely to be receiving warfarin and antiarrhythmic drugs and had a slightly higher left ventricular ejection fraction. After a mean follow-up of 236 +/- 303 days, 98 patients died: 56 (57%) died suddenly, and 36 (37%) died of progressive heart failure. Actuarial 1-year overall survival was 68%, and sudden death-free survival was 79%. Actuarial survival was significantly worse for atrial fibrillation than for sinus rhythm patients (52% versus 71%, p = 0.0013). Similarly, sudden death-free survival was significantly worse for atrial fibrillation than for sinus rhythm patients (69% versus 82%, p = 0.0013). By Cox proportional hazards model, pulmonary capillary wedge pressure on therapy, left ventricular ejection fraction, coronary artery disease, and atrial fibrillation were independent risk factors for total mortality and sudden death. For patients who had pulmonary capillary wedge pressure of less than 16 mm Hg on therapy, atrial fibrillation was associated with poorer 1-year survival (44% versus 83%, p = 0.00001); however, in the high pulmonary capillary wedge pressure group, atrial fibrillation did not confer an increased risk (58% versus 57%).
CONCLUSIONS: Atrial fibrillation is a marker for increased risk of death, especially in heart failure patients who have lower filling pressures on vasodilator and diuretic therapy. Whether aggressive attempts to maintain sinus rhythm will reduce this risk is unknown.

Entities:  

Mesh:

Year:  1991        PMID: 2060110     DOI: 10.1161/01.cir.84.1.40

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  83 in total

Review 1.  Clinical relevance of silent atrial fibrillation: prevalence, prognosis, quality of life, and management.

Authors:  I Savelieva; A J Camm
Journal:  J Interv Card Electrophysiol       Date:  2000-06       Impact factor: 1.900

2.  Heart rate turbulence for prediction of heart transplantation and mortality in chronic heart failure.

Authors:  Beata Sredniawa; Sylwia Cebula; Jacek Kowalczyk; Velislav N Batchvarov; Agata Musialik-Lydka; Anna Sliwinska; Aleksandra Wozniak; Michal Zakliczynski; Marian Zembala; Zbigniew Kalarus
Journal:  Ann Noninvasive Electrocardiol       Date:  2010-07       Impact factor: 1.468

3.  Prognostic significance of atrial fibrillation is a function of left ventricular ejection fraction.

Authors:  Ramdas G Pai; Padmini Varadarajan
Journal:  Clin Cardiol       Date:  2007-07       Impact factor: 2.882

4.  Atrial fibrillation: now one of the most common causes for hospitalization.

Authors:  Joseph S Alpert
Journal:  Curr Cardiol Rep       Date:  2005-05       Impact factor: 2.931

5.  Non-invasive cardiac evaluation in heart failure patients using magnetic resonance imaging: a feasibility study.

Authors:  Stephanie M Shors; William G Cotts; Biljana Pavlovic-Surjancev; Mihai Gheorghiade; James C Carr; Richard M McCarthy; Scott F Pereles; Paul J Finn
Journal:  Heart Fail Rev       Date:  2005-12       Impact factor: 4.214

6.  Glucose and haemoglobin in the assessment of prognosis after first hospitalisation for heart failure.

Authors:  J D Newton; I B Squire
Journal:  Heart       Date:  2006-04-18       Impact factor: 5.994

Review 7.  Is aspirin safe for patients with heart failure?

Authors:  J G Cleland; C J Bulpitt; R H Falk; I N Findlay; C M Oakley; G Murray; P A Poole-Wilson; C R Prentice; G C Sutton
Journal:  Br Heart J       Date:  1995-09

8.  Effect of bucindolol on heart failure outcomes and heart rate response in patients with reduced ejection fraction heart failure and atrial fibrillation.

Authors:  David P Kao; Gordon Davis; Ryan Aleong; Christopher M O'Connor; Mona Fiuzat; Peter E Carson; Inder S Anand; Jonathan F Plehn; Stephen S Gottlieb; Marc A Silver; JoAnn Lindenfeld; Alan B Miller; Michel White; Guinevere A Murphy; Will Sauer; Michael R Bristow
Journal:  Eur J Heart Fail       Date:  2012-12-07       Impact factor: 15.534

Review 9.  Comorbidity of atrial fibrillation and heart failure.

Authors:  Liang-Han Ling; Peter M Kistler; Jonathan M Kalman; Richard J Schilling; Ross J Hunter
Journal:  Nat Rev Cardiol       Date:  2015-12-10       Impact factor: 32.419

10.  Telemedical support in patients with chronic heart failure: experience from different projects in Germany.

Authors:  Axel Müller; Johannes Schweizer; Thomas M Helms; Micheal Oeff; Claudia Sprenger; Christian Zugck
Journal:  Int J Telemed Appl       Date:  2010-08-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.